What is Pacific Biosciences of California PB Ratio?
Pacific Biosciences of CaliforniaPACB +11.11%53 PB Ratio is 200.00 as of Jun. 26, 2026, which is 3517% above its 10-year median of 5.53. GuruFocus rates PACB with a GF Score™ of 53/100 and a GF Value™ of $1.62 (Fairly Valued). The stock has 8 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Pacific Biosciences of California ranks worse than 99.75% on this metric.
PACB'
s PB Ratio Range Over the Past 10 Years
Min: 0.57 Med: 5.53 Max: 211.25
Current: 200
During the past 13 years, Pacific Biosciences of California's highest PB Ratio was 211.25. The lowest was 0.57. And the median was 5.53.
PACB's PB Ratio is ranked worse than 99.75% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.02
vs PACB: 200.00
During the past 12 months, Pacific Biosciences of California's average Book Value Per Share Growth Rate was -97.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -80.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -51.10% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -7.60% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Pacific Biosciences of California was 90.60% per year. The lowest was -80.70% per year. And the median was -6.20% per year.
Back to Basics: PB Ratio
Pacific Biosciences of California (NAS:PACB) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Pacific Biosciences of California PB Ratio Related Terms
Pacific Biosciences of California PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Pacific Biosciences of California's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pacific Biosciences of California PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Pacific Biosciences of California's PB Ratio distribution charts can be found below:
* The bar in red indicates where Pacific Biosciences of California's PB Ratio falls into.
Pacific Biosciences of California PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Pacific Biosciences of California (PACB) has a PB Ratio of 200.00 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Pacific Biosciences of California and its competitors. This is 3517% above median its historical median of 5.53. Over the past decade, Pacific Biosciences of California's PB Ratio has ranged from 0.57 to 211.25. According to the industry distribution chart, Pacific Biosciences of California ranks #786 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 99.7%.
Is Pacific Biosciences of California's PB Ratio too high?
Pacific Biosciences of California's current PB Ratio of 200.00 is 3517% above median its 10-year median of 5.53. Over the past 10 years, this metric has ranged from a low of 0.57 to a high of 211.25. The Medical Devices & Instruments industry median PB Ratio is 2.02. Pacific Biosciences of California's value of 200.00 is 9801% above this industry median. Based on the distribution chart, Pacific Biosciences of California ranks #786 out of 788 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Pacific Biosciences of California has a GF Score™ of 53/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pacific Biosciences of California's PB Ratio compare to CATX and LAB?
According to the Medical Devices & Instruments industry distribution chart, Pacific Biosciences of California ranks #786 out of 788 companies for PB Ratio. This places Pacific Biosciences of California in the lower half of its industry. The industry median PB Ratio is 2.02. Pacific Biosciences of California's value of 200.00 is 9801% above this benchmark. Historically, Pacific Biosciences of California's own PB Ratio has ranged from 0.57 to 211.25 over the past decade. While the company's 10-year median is 5.53 vs. the industry median of 2.02, Pacific Biosciences of California has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.02, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pacific Biosciences of California's current PB Ratio of 200.00 is 9801% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Pacific Biosciences of California and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pacific Biosciences of California's current PB Ratio is 200.00, which is 3517% above median its own 10-year median of 5.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pacific Biosciences of California stock overvalued right now?
Based on GuruFocus' analysis, Pacific Biosciences of California (PACB) is currently considered Fairly Valued. The stock's GF Value™ is $1.62, compared to a current price of $1.60 — trading 1.2% below its estimated fair value. The current PB Ratio is 200.00, which is 3517% above median its 10-year median of 5.53 and 9801% above the Medical Devices & Instruments industry median of 2.02. Pacific Biosciences of California's overall GF Score™ is 53/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Pacific Biosciences of California (PACB), the current PB Ratio is 200.00 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pacific Biosciences of California (PACB) Overvalued in 2026?
Based on GuruFocus' analysis, Pacific Biosciences of California stock appears to be undervalued.
The current stock price of $1.60 is trading 1.2% below its estimated GF Value™ of $1.62.
GuruFocus considers Pacific Biosciences of California to be Fairly Valued.
Key valuation signals for PACB:
PB Ratio: 200.00 (3517% above median its 10-year median of 5.53)
GF Value™: $1.62 vs. price of $1.60 (1.2% below fair value)
Industry Position: 9801% above the Medical Devices & Instruments median (#786 of 788)
No single metric tells the full story. See the PACB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pacific Biosciences of California Business Description
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
53GF Score
Get the complete analysis for PACB
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PACB has been successfully added to your 
